Answers are grounded in this paper and cite their sources.
A randomized, controlled trial finds comparable safety and efficacy in stimulating two brain regions for Meige syndrome, suggesting optimal treatment approaches.
GPi-DBS and STN-DBS demonstrate comparable safety and efficacy in patients with MeS. STN-DBS requires lower stimulation parameters than GPi-DBS. The optimal stimulation sites are the posterolateral dorsal GPi and the dorsal STN. Greater preoperative speech/swallowing impairment predicts poorer outcomes.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: